Fennec Pharmaceuticals annual revenue
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2022
2023
2024
2025
Fennec Pharmaceuticals Revenue Growth & History (FENC)
Fennec Pharmaceuticals reported $44.6M in revenue for fiscal 2025, a decrease of 6.09% from the previous fiscal year.
View full Fennec Pharmaceuticals company overviewFennec Pharmaceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $44.6M | −$2.9M | −6.09% |
| 2024 | 2024-12-31 | $47.5M | $23.8M | +99.89% |
| 2023 | 2023-12-31 | $23.8M | $22.0M | +1244.38% |
| 2022 | 2022-12-31 | $1.8M | — | — |
| 2020 | 2020-12-31 | $170,000 | $170,000 | — |
| 2019 | 2019-12-31 | $0 | $0 | — |
| 2018 | 2018-12-31 | $0 | $0 | — |
| 2017 | 2017-12-31 | $0 | $0 | — |
| 2016 | 2016-12-31 | $0 | $0 | — |
| 2015 | 2015-12-31 | $0 | $0 | — |
| 2014 | 2014-12-31 | $0 | $0 | — |
| 2013 | 2013-12-31 | $0 | $0 | — |
| 2012 | 2012-12-31 | $0 | $0 | — |
| 2011 | 2011-12-31 | $0 | — | — |
Fennec Pharmaceuticals quarterly revenue
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $17.9M | $8.2M | +85.18% |
| Q1 2026 | 2026-03-31 | $15.1M | $6.4M | +72.64% |
| Q4 2025 | 2025-12-31 | $13.8M | $5.9M | +73.84% |
| Q3 2025 | 2025-09-30 | $12.5M | $5.5M | +78.69% |
| Q2 2025 | 2025-06-30 | $9.7M | $2.4M | +32.91% |
| Q1 2025 | 2025-03-31 | $8.8M | −$16.6M | −65.52% |
| Q4 2024 | 2024-12-31 | $7.9M | −$4.3M | −35.39% |
| Q3 2024 | 2024-09-30 | $7.0M | $459,000 | +7.05% |
| Q2 2024 | 2024-06-30 | $7.3M | $3.9M | +118.41% |
| Q1 2024 | 2024-03-31 | $25.4M | $23.7M | +1413.24% |
| Q4 2023 | 2023-12-31 | $12.3M | — | — |
| Q3 2023 | 2023-09-30 | $6.5M | — | — |
| Q2 2023 | 2023-06-30 | $3.3M | — | — |
| Q1 2023 | 2023-03-31 | $1.7M | — | — |
| Q1 2021 | 2021-03-31 | $0 | $0 | — |
| Q4 2020 | 2020-12-31 | $170,000 | $170,000 | — |
| Q3 2020 | 2020-09-30 | $0 | $0 | — |
| Q2 2020 | 2020-06-30 | $0 | $0 | — |
| Q1 2020 | 2020-03-31 | $0 | $0 | — |
| Q4 2019 | 2019-12-31 | $0 | $0 | — |
| Q3 2019 | 2019-09-30 | $0 | $0 | — |
| Q2 2019 | 2019-06-30 | $0 | $0 | — |
| Q1 2019 | 2019-03-31 | $0 | $0 | — |
| Q4 2018 | 2018-12-31 | $0 | $0 | — |
| Q3 2018 | 2018-09-30 | $0 | $0 | — |
| Q2 2018 | 2018-06-30 | $0 | $0 | — |
| Q1 2018 | 2018-03-31 | $0 | $0 | — |
| Q4 2017 | 2017-12-31 | $0 | $0 | — |
| Q3 2017 | 2017-09-30 | $0 | $0 | — |
| Q2 2017 | 2017-06-30 | $0 | $0 | — |
| Q1 2017 | 2017-03-31 | $0 | $0 | — |
| Q4 2016 | 2016-12-31 | $0 | $0 | — |
| Q3 2016 | 2016-09-30 | $0 | $0 | — |
| Q2 2016 | 2016-06-30 | $0 | $0 | — |
| Q1 2016 | 2016-03-31 | $0 | $0 | — |
| Q4 2015 | 2015-12-31 | $0 | $0 | — |
| Q3 2015 | 2015-09-30 | $0 | $0 | — |
| Q2 2015 | 2015-06-30 | $0 | $0 | — |
| Q1 2015 | 2015-03-31 | $0 | $0 | — |
| Q4 2014 | 2014-12-31 | $0 | $0 | — |
| Q3 2014 | 2014-09-30 | $0 | $0 | — |
| Q2 2014 | 2014-06-30 | $0 | $0 | — |
| Q1 2014 | 2014-03-31 | $0 | $0 | — |
| Q4 2013 | 2013-12-31 | $0 | $0 | — |
| Q3 2013 | 2013-09-30 | $0 | $0 | — |
| Q2 2013 | 2013-06-30 | $0 | $0 | — |
| Q1 2013 | 2013-03-31 | $0 | $0 | — |
| Q4 2012 | 2012-12-31 | $0 | $0 | — |
| Q3 2012 | 2012-09-30 | $0 | $0 | — |
| Q2 2012 | 2012-06-30 | $0 | $0 | — |
| Q1 2012 | 2012-03-31 | $0 | $0 | — |
| Q4 2011 | 2011-12-31 | $0 | — | — |
| Q3 2011 | 2011-09-30 | $0 | — | — |
| Q2 2011 | 2011-06-30 | $0 | — | — |
| Q1 2011 | 2011-03-31 | $0 | — | — |
Fennec Pharmaceuticals revenue growth trends
Over the last five reported fiscal years, revenue grew from $170,000 to $44.6M, a compound annual growth rate of 204.69%. Fennec Pharmaceuticals's latest reported quarter, Q2 2026, generated $17.9M in revenue, an increase of 85.18% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Fennec Pharmaceuticals source filings ↗